YBX3 and nonpapillary renal cell carcinoma: The results suggested that ccRCC with overexpression of YBX3 had a poorer prognosis, was associated with more male patients, and had an elevated rate of tumor progression to the advanced stages compared to ccRCC with low YBX3 expression.